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Abstract 60 
Purpose 61 
Caregiver burden, quality of life (QOL) and unmet needs are poorly understood, 62 
particularly at the end of life. We explored these issues in caregivers of women with 63 
ovarian cancer.  64 
Patients and Methods 65 
The Australian Ovarian Cancer Study (AOCS) is a prospective population-based study of 66 
women newly diagnosed with primary epithelial ovarian cancer. Ninety-nine caregivers 67 
of women participating in the AOCS QOL sub-study (88% response rate) rated their 68 
QOL (SF-12), psychological distress (HADS), optimism (LOT), social support (Duke) 69 
and unmet needs (SCNS-carers), and patients rated their QOL (FACT-O), every three 70 
months for two years. This analysis included measurements in the patient’s last year of 71 
life.  72 
Results 73 
Caregivers had significantly lower mental and physical QOL than population norms 74 
(p<0.01). Mean distress (p=0.01) and unmet needs increased over time, however social 75 
support remained constant. In linear mixed models, (using scores for each psychosocial 76 
variable over time), optimism (p<0.0001), social support (p<0.0001), higher unmet needs 77 
(p=0.008), physical wellbeing (p<0.0001), and time to death (p<0.0001) but not patient 78 
QOL, predicted caregiver mental well-being and distress. Highest unmet needs in the last 79 
6 months related to managing emotions about prognosis, fear of cancer spread, balancing 80 
one’s own and the patient’s needs, impact of caring on work and making decisions in the 81 
context of uncertainty.  82 
 4 
 83 
Conclusions 84 
Aspects of caregiver functioning, rather than patient quality of life, predict caregiver 85 
quality of life and distress. Caregivers need help with managing emotions about 86 
prognosis, balancing their own and the patient’s needs, work, and decision-making when 87 
there is uncertainty.  88 
  89 
 5 
Introduction 90 
Ovarian cancer places a particularly significant burden on patients and their family 91 
members, due to its high mortality rate and complex, prolonged, multimodal treatments 92 
[1].  It is a disease characterised by multiple recurrences and many lines of chemotherapy, 93 
with decreasing duration of benefit over time.  94 
 95 
Family members are often called upon to provide emotional and practical support, and 96 
physical care [1]. Caregivers often feel unprepared for this role [1], and can also 97 
experience financial stress if unable to maintain income-generating activity, existential 98 
distress and anxiety related to future uncertainty [1]. Studies have documented higher 99 
levels of distress and poorer quality of life in caregivers compared to controls, and 100 
significant needs for informational, practical and emotional support [2]. Further, poorer 101 
physical health due to the strain of caregiving can increase caregivers’ own risk of 102 
mortality [3,4]. 103 
  104 
Predictors of high caregiver distress include other life stresses [5], poorer social support 105 
[6], lower social economic status and younger age [7,8], lower carer optimism [9] and a 106 
closer caregiver-patient relationship [8]. Caregiver distress also increases with greater 107 
patient physical impairment and need for palliative care [10]. Thus supporting carers 108 
during the final months of illness is particularly important. Despite this, little research has 109 
focused on caregiver experiences at this time, with very few studies specifically focused 110 
on caregivers of women with ovarian cancer. Caregivers of women with ovarian cancer 111 
may have unique concerns, give that they are primarily male (husbands), and given the 112 
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complex, repeated treatment regimens and high symptom burden in the last year of life in 113 
ovarian cancer.  114 
 115 
Only two quantitative studies have explored caregiver QOL in ovarian cancer. One cross-116 
sectional study found significantly higher anxiety and depression in 373 caregivers 117 
compared to controls [11]. Another study [12] of 30 caregivers found their QOL 118 
improved on completion of chemotherapy, regardless of the patient’s tumour response. 119 
Caregiver QOL was correlated with patient worry, distress and functioning. Neither of 120 
these studies focused specifically on issues for caregivers at the end of life.  121 
 122 
Therefore the aims of this longitudinal study were, in the patient’s last year of life, to: 123 
 124 
1) Describe the QOL of caregivers of women with ovarian cancer  125 
2) Describe the most frequent and severe unmet needs in caregivers  126 
3) Identify caregiver and patient predictors of caregiver quality of life  127 
 128 
Methods 129 
 130 
Participants and procedures 131 
 132 
Participants included in this analysis were women taking part in the Australian Ovarian 133 
Cancer Study QOL study (AOCS-QOL) and their nominated primary support person 134 
(caregiver). AOCS is a prospective population-based study that recruited women aged 135 
 7 
18–79 years newly diagnosed with primary epithelial ovarian cancer (including fallopian 136 
tube and primary peritoneal cancers) between 2002 and 2006 [13]. Women were 137 
recruited through major treatment centres and state-based cancer-registries. The AOCS 138 
has collected detailed epidemiological, pathology and initial treatment data, as well as 139 
ongoing treatment and clinical outcome data [13]. 140 
 141 
The AOCS-QOL study investigated the role of psychosocial factors in predicting patient 142 
and caregiver outcomes, recruiting AOCS participants who were alive in May 2005 or 143 
recruited to AOCS after this date [14]. Initial contact was made by AOCS to preserve 144 
confidentiality. Consenting women were mailed an information statement, consent form, 145 
questionnaire booklet and a reply paid envelope, and a request to invite their primary 146 
caregiver (over the age of 18) to also participate in the study. Women were 3–55 months 147 
post-diagnosis (mean 25.8 months) at study entry [13,14]. 148 
 149 
Measures of quality of life, psychological distress, optimism, social support, and unmet 150 
needs were collected by validated measures from both patients and caregivers at three-151 
monthly intervals for up to two years. If more than one item on any questionnaire was 152 
missing, the participant was contacted; missing psychosocial data are therefore minimal. 153 
 154 
The current analyses include 99 caregivers who completed at least one assessment within 155 
the last year of life of the woman for whom they were caring. The study was approved 156 
and conducted in accordance with the ethical standards of the University of Sydney, 157 
Queensland Institute of Medical Research Human Research Ethics Committees and all 158 
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participating sites across Australia. 159 
 160 
Measures 161 
 162 
Primary outcome variable 163 
The primary outcome variable is caregiver QOL, measured using the 12-item Short Form 164 
– version 2 (SF-12v2) of the Health Survey [15]. The SF-12v2 is the most widely used 165 
health related QOL measure in the general population and consists of two components, 166 
physical health (PCS) and mental health (MCS). Higher scores indicate better QOL. 167 
Australian population norms for the SF-12v2 were obtained from the Australian Bureau 168 
of Statistics, collected in 1997. 169 
 170 
Demographic and treatment variables 171 
Carer age, gender, education, marital status, occupational status and relationship to the 172 
patient were self-reported via questionnaire. Place of residence (major city or 173 
regional/remote) was determined from residential postcodes. Date of patient’s cancer 174 
diagnosis was obtained through the AOCS. Current treatment data (on chemotherapy/ 175 
radiotherapy or not) was self-reported with each patient questionnaire.  176 
 177 
Carer Psychosocial variables 178 
Hospital Anxiety and Depression Scale (HADS) [16]. The 14-item HADS measures 179 
anxiety (7 items) and depression (7 items). Total scores (combining sub-scales) measure 180 
distress. Higher scores indicate greater morbidity. 181 
 9 
 182 
Duke-UNC Functional Social Support Questionnaire [17]. This 8-item scale, developed 183 
for use in general practice settings, measures satisfaction with the functional and affective 184 
aspects of social support. Higher scores indicate better social support. 185 
 186 
Life Orientation Test-Revised (LOT-R) [18]. This 10-item scale measures dispositional 187 
optimism; higher scores indicate greater optimism.  188 
 189 
Supportive Care Needs Survey (SCNS)-carers version [19].  This 44 item questionnaire 190 
was adapted from a measure developed for caregivers of cancer survivors. Respondents 191 
indicate on a 5-point scale whether they have a need, and if so, how strong that need is. 192 
Higher scores indicate greater need. 193 
 194 
Patient quality of life 195 
Functional Assessment of Cancer Therapy-Ovarian scale (FACT-O-version 4) [20]. This 196 
ovarian cancer-specific QOL instrument assesses the four core QoL domains of physical 197 
(7 items), social (7 items), emotional (6 items) and functional wellbeing (7 items), 198 
together with 11 additional items assessing disease and treatment issues specific to 199 
ovarian cancer (symptom burden). Higher scores indicate better QOL.  200 
 201 
Statistical Methods 202 
Patient and caregiver data were merged by patient ID and by matching caregiver 203 
assessment date to the closest patient assessment date within 1 month. Months to patient 204 
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death was calculated as the date of death minus the patient’s assessment date, rounded to 205 
the nearest month.  206 
 207 
The primary outcomes (SF-12v2 mental and physical wellbeing) were scored according 208 
to author guidelines using population norms (mean 50, standard deviation 10). We tested 209 
the proportion of participants who scored below 1 SD against the expected value of 16% 210 
(assuming the aforementioned normal distribution) using one sample tests of proportions. 211 
Distress, as measured by the total HADS, was also investigated.  212 
 213 
Individual unmet need items were recoded as no need (0) or any need (1) and scored as 214 
recommended in the SCNS manual. Total scores for each sub-domain (physical, 215 
psychological, sexual, supportive care and information) were standardised to 100. The 216 
total unmet needs score was the average of the five domains, with a possible range of 0-217 
100. The top five (or more if there were ties) prevalent unmet needs were computed for 218 
the four 3-month periods, where prevalence was defined as the proportion of women 219 
reporting 3 or greater. Mean severity amongst those with any unmet needs was computed 220 
also.  221 
 222 
The associations between baseline psychosocial variables with QOL and distress were 223 
investigated using linear mixed models. Mixed models account for the correlation within 224 
participant due to repeated measures on participants and give unbiased estimation for data 225 
which are missing completely at random and at random [21]. All statistical analyses were 226 
performed in SAS version 9.3 (Cary, NC).  227 
 11 
 228 
Each participant’s first observation in the year preceding death (referred to as “baseline”) 229 
for psychosocial variables was used to predict all subsequent observations of the 230 
outcomes. In addition to the psychosocial variables, fixed effects of caregiver age, 231 
months to patient death and patient current treatment (yes/no: radiotherapy or 232 
chemotherapy); and a random effect of patient were included in the model. Caregiver sex, 233 
relationship to patient and rurality were also considered, but were excluded due to lack of 234 
association with outcomes. 235 
 236 
Each outcome measure was also modeled with time-varying psychosocial covariates, to 237 
investigate on-going effects of possible changes in the psychosocial variables over time. 238 
Models were pre-specified, and based on theoretical and background knowledge.  239 
 240 
The following variables were graphed over time (months to death), with 95% confidence 241 
intervals (CI): mental wellbeing (SF-12v2), physical wellbeing (SF-12v2), distress 242 
(HADS), unmet needs (SCNS-Carers) and social support (Duke).  243 
 244 
Results 245 
 246 
Of 798 women with ovarian cancer who participated in the AOCS-QOL study, 423 247 
nominated caregivers, and of these, 373 (a response rate of 88%), agreed to participate. 248 
Of these, 99 caregivers had at least 1 assessment point during the patient’s last year of 249 
life, with a total of 203 assessments. Thirty-eight participants (38%) had one assessment 250 
only, 28 (28%) had two assessments, 23 (23%) had three assessments, and 10 (10%) had 251 
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four assessments. Thirty-three assessments were in the last 3 months of life, 57 252 
assessments were from 4-6 months before death, 61 were from 7-9 months before death 253 
and 51 assessments were between 10 and 12 months from death.  254 
 255 
We compared the 99 participants from this study with the 118 women for whom we had 256 
data from the last year of life who did not have a participating carer. Women with carers 257 
were more likely to be married or partnered (56% versus 18%), but there were no 258 
statistically or clinically significant differences in age, quality of life, distress, social 259 
support or needs at the first assessment in their last year of life. 260 
 261 
Patient and caregiver characteristics are shown in Table 1. Caregivers were on average 59 262 
years old, mostly male (80%) and married to the patient (78%). Sixteen percent were 263 
children of the patient while 6% were in another relationship. One third (37%) were 264 
employed and most (63%) lived in a major city. Patients were on average 31 months 265 
since diagnosis with just over half (51%) on treatment at baseline.   266 
 267 
Table 1 about here 268 
 269 
QOL 270 
High proportions of caregivers had low mental wellbeing, as compared to the population 271 
norm of 16%, at 7-9 months before patient’s death (30%, p=0.008), at 4-6 months (32%, 272 
p=0.003) and at 0-3 months before patient’s death (39%, p=0.001). The proportion of 273 
participants with lower physical wellbeing than the population norm was statistically 274 
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significantly higher at 4-6 months only (30%, p=0.01), although there was a trend 275 
towards worse physical quality of life at 0-3 months also (27%, p=0.09) (see Table 2). 276 
Figure 1 shows that mean levels for both mental and physical well-being declined slightly 277 
over the 12 month study period. 278 
 279 
Table 2 about here 280 
 281 
Psychosocial trajectories 282 
Mean distress levels in caregivers increased significantly over time (p=0.01, Figure 1). 283 
The number of unmet needs also increased over time, although this was not statistically 284 
significant. However social support remained constant, suggesting that social support did 285 
not increase in proportion with growing distress and need for this group of caregivers.  286 
 287 
Unmet needs 288 
Fifty-six percent of caregivers reported at least one unmet need in the period 10-12 289 
months before the patient’s death, 70% 7-9 months, 83% 4-6 months and 88% 0-3 290 
months (chisquare test of trend, p = 0.0007). The top five (or more if tied) prevalent 291 
unmet needs of caregivers at each 3 month interval before the patient’s death, are shown 292 
in Table 3. The severity of unmet needs increased over time, peaking 3-6 months before 293 
death, but reducing in the last 0-2 months of the patient’s life. At the beginning of the 294 
year, the most prevalent and severe unmet needs were for more support from other family 295 
members, reducing the patient’s stress and addressing sex life problems. Reducing the 296 
patient’s stress became the top priority for the remainder of the year, with accessing 297 
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prognostic information, handling the topic of cancer in social situations and dealing with 298 
lack of acknowledgement of the impact on being a caregiver, taking 2nd and 3rd places 299 
during this time.  300 
 301 
Disappointment about lack of recovery and fear of the cancer spreading became 302 
prominent in the last few months of the patient’s life. Interestingly, working through 303 
feelings about death and dying were amongst the top five unmet needs only at the 304 
beginning of the year, suggesting a relatively early acknowledgement of approaching 305 
death. Other issues which reached the top five only in the last three months, included 306 
balancing one’s own needs with those of the patient’s, the impact of caring on work 307 
activities and making decisions in the context of uncertainty.  308 
 309 
Factors associated with QOL 310 
Results of the mixed model analyses using baseline variables as predictors are shown in 311 
Table 4. We excluded patient’s current treatment from the models because it was not 312 
statistically significant in any of them, and its estimated effects were small. Mental 313 
wellbeing was positively associated with baseline optimism (p=0.01) and social support 314 
(p=0.002) and negatively associated with patients’ baseline QoL (p=0.02). Similarly, 315 
worse distress (total HADS) was associated with lower baseline optimism (p=0.01) and 316 
social support (p=0.02) and with higher unmet needs (p=0.02). Physical wellbeing was 317 
not associated with any of the measured variables.  318 
 319 
Table 4 about here 320 
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 321 
Associations were similar but stronger in the time-varying model (Table 4), which 322 
showed that mental wellbeing was significantly positively associated with current 323 
optimism (p<0.0001) and social support (p<0.0001) and negatively associated with 324 
higher unmet needs (p=0.008) and physical wellbeing (p<0.0001), but not patient QOL 325 
(p=0.9).  Similarly, distress was significantly lower in women with high current optimism 326 
and social support, and higher in those with high unmet needs (p=0.0005) and fewer 327 
months to death (p<0.0001). Physical wellbeing was negatively associated with mental 328 
wellbeing (p<0.0001) and positively associated with social support (p=0.02) in the time-329 
varying model. Notably, caregiver age was not related to outcomes in either model.  330 
 331 
Discussion 332 
 333 
This large prospective study provides the first available data on the experience of 334 
caregivers of women with recurrent ovarian cancer throughout the women’s last year of 335 
life. Documenting the trajectories of caregivers’ physical and mental QoL, distress, 336 
unmet needs and social support over the last year of life, the findings clearly demonstrate 337 
deterioration in mental wellbeing and an increase in distress in the 12 months before 338 
death. Both mental and physical wellbeing was compromised for caregivers, particularly 339 
in the last 6 months of the patient’s life. A third of caregivers reported scores which fell 340 
below one standard deviation of population norms, representing a clinically significantly 341 
reduction in quality of life. Furthermore, scores remained consistently poor over the year. 342 
This is a significant concern not only for the caregivers themselves, but also because 343 
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these caregivers are so vital to supporting the patients, and reinforces previous studies 344 
that have shown that caregiving has a real toll on caregivers [1].  345 
 346 
Distress and needs increased over time, but social support remained constant. This 347 
suggests that social support did not increase to match the caregivers’ growing needs. As 348 
social support was consistently associated with better wellbeing, this deficiency clearly 349 
has an important impact on caregivers. Of note, caregiver distress was also impacted by 350 
needs not being met by cancer services, suggesting that caregivers need support not only 351 
from family and friends but also from their cancer team. Unmet needs increased steadily 352 
over time, decreasing only in the last three months of the patient’s life, when perhaps 353 
palliative care staff were more involved. Traditionally cancer services have focused on 354 
patient care, but these findings suggest that caregivers should also be a focus for active 355 
monitoring and intervention. 356 
 357 
Caregiver unmet needs shifted over time, from an initial focus on obtaining support for 358 
the wider family, discussing the cancer in social situations and on issues around 359 
sexuality, to needing help with disappointment and fear, and making decisions under 360 
conditions of uncertainty at the end of the year. This maps well to the change over time 361 
from living with cancer, to preparing for death. Early unmet needs were similar to those 362 
identified by Soothill et al [22], in caregivers of heterogeneous cancer patients, for help 363 
with managing daily life, emotions and social identify. However, later unmet needs 364 
appear to be unique to the period close to death. These data provide some useful guidance 365 
to cancer services on the issues likely to be paramount for caregivers at different points of 366 
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the cancer trajectory. In particular, these findings suggest that caregivers could benefit 367 
from early contact with psychosocial staff for help with managing current and future 368 
losses, rather than waiting for post-death referral to bereavement services. Further, during 369 
the entire treatment phase, these caregivers reported strong needs for information, 370 
suggesting that they may need individual consultations with nursing and medical staff, 371 
and access to information resources and support groups targeted to their needs.  372 
 373 
Apart from social support, caregiver optimism, both at baseline and over the entire year, 374 
was associated with better mental wellbeing and lower distress. Optimistic caregivers 375 
were perhaps better able to cope with the disappointment and fear that increased as death 376 
approached. Optimism has previously been shown to be associated with improved quality 377 
of life [23] and even survival, but has primarily been explored in relation to patient, 378 
rather than caregiver, outcomes. Caregivers often use a wide array of coping behaviours 379 
in response to the stress encountered [1], and the place of optimism amongst this array 380 
requires further research.  381 
 382 
Interestingly, the patient being on treatment was not associated with decreased caregiver 383 
QOL, reinforcing the findings summarized by Le et al [1]. Perhaps the hope provided by 384 
treatment counter-acts the challenges of side effects and tumor progression. Furthermore, 385 
while patient self-reported quality of life at baseline was associated with caregiver mental 386 
wellbeing, when considered over time it was not a significant predictor. Perhaps the 387 
situation of caring for someone with advanced cancer is so overwhelming that variations 388 
in the patient’s reported quality of life are not enough to mitigate caregiver concerns. 389 
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Similar findings have been reported in recent research exploring caregiver distress at the 390 
end of life. Tang, Siew, Cheng et al [24], for example, reported that the caregiver’s sense 391 
of coherence moderated the impact of caregiver burden on their stress, and noted that 392 
theories of stress and coping suggest that the impact of caregiving on caregivers’ lives 393 
depends more on personal psychological resources than on objective caregiving demands 394 
or social resources. 395 
 396 
Strengths and Limitations, and future directions 397 
 398 
As part of a large cohort study, the women cared for by the caregivers in this analysis 399 
were recruited across stages of disease and at varying times since diagnosis. However, as 400 
our interest was in the last year of life, this heterogeneity had little impact on results. 401 
Further, with up to eight assessment points, we were able to closely track these caregivers 402 
over a year, and include time-varying variables in the analyses. Another strength is the 403 
population-based nature of the cohort, who were recruited from all major centres treating 404 
women with ovarian cancer as well as via cancer registries across Australia.  405 
 406 
It is often challenging to gain access to caregivers in order to invite them into research 407 
studies, as by necessity identification and contact of caregivers has to occur via the 408 
patients for whom they are caring. While our initial response rate of caregivers for this 409 
study was high (88%), only 53% of patients nominated a caregiver for the study, and it is 410 
possible that these data do not fully reflect outcomes for all caregivers of women with 411 
ovarian cancer. As we did not have informed consent from the women who did not 412 
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nominate a caregiver to examine their characteristics, we could not explore systematic 413 
differences between these women and those who did nominate a caregiver.  414 
 415 
Future research could usefully evaluate interventions targeting caregivers of women with 416 
ovarian cancer across the disease trajectory to reduce their distress and allow them to 417 
maintain as optimal quality of life as possible during this challenging time.  418 
 419 
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Table 1. Carer and patient demographics and characteristics, disease and treatment 434 
at the first assessment during the last year of life.  435 
Mean and standard deviation (SD) for continuous variables, and frequency and 436 
percentage for categorical variables are shown.  437 
 438 
Carers (n = 99)  Mean (SD) or n (%) 
Age (years) 59 (13.2) 
Age group (years)  
  ≤40  8 (8) 
  41-50 15 (15) 
  51-60 23 (23) 
  61-70 31 (32) 
  >70 21 (21) 
Gender (male) 80 (80) 
Relationship to patient  
   Husband or partner 77 (78) 
   Child 16 (16) 
   Sibling or friend 6 (6) 
Married or partnered  
     Current partner 88 (89) 
      Not partnered 11 (11) 
Work status  
   Full time 38 (37) 
   Part time 2 (2) 
   Not employed/missing 62 (61) 
Education  
     School only (≤12 years) 27 (27) 
     Trade/Technical 53 (54) 
     University 19 (19) 
Residential location  
    Major city 64 (63) 
    Regional/remote 38 (37) 
Social support (possible range 8-40) 60 (13.1) 
Optimism (possible range 0-24) 15 (4.8) 
Unmet needs severity (possible range 0-
100) 
33 (19.1)  
Mental health2 (possible range (0-100) 44 (10.9) 
Physical health (possible range 0-100) 49 (11.3) 
Distress (possible range 0-42) 14 (7.7) 
Patients (n = 99)  
Age mean years (standard deviation) 63 (8.7) 
Age group (years)  
  ≤40 4 (4) 
  41-50 17 (17) 
 24 
  51-60 33 (33) 
  61-70 28 (28) 
  >70 17 (17) 
On treatment at baseline 51 (51) 
Months since diagnosis 31 (14.3) 
Quality of life (possible range 0-100) 74 (15.2) 
1Numbers may not add up to total due to missing data 439 
2 population mean = 50, SD = 10  440 
 441 
 442 
443 
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Table 2. Number (%) of caregivers below one standard deviation (SD) of population 444 
norms for mental wellbeing and physical wellbeing SF-12v2. 445 
 446 
 Mental wellbeing Physical wellbeing 
Months before 
death  
n (%) 1 SD below 
norms 
p-value1 n (%) 1 SD 
below norms 
p-value1 
10-12 months 
n = 51 
10 (20%) 0.4 11 (22%) 0.3 
7-9 months 
n = 61 
18 (30%) 0.008 13 (21%) 0.3 
4-6 months 
n = 57 
18 (32%) 0.003 17 (30%) 0.01 
0-3 months 
n = 33 
13 (39%) 0.001 9 (27%) 0.09 
1 One-sample proportion test, against US population norms, where 16% are expected to 447 
be less than 1 SD. 448 
 449 
 450 
451 
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Table 3. Top five (or more if tied) most prevalent unmet needs for caregivers at 10 452 
to 12, 7 to 9, 4 to 6, and 0-3 months preceding patient death and mean severity. N 453 
gives number of non-missing observations.  454 
 455 
Months 
before death 
Unmet need1 Number 
reporting 
any need 
Prevalence2 
(95% CI) 
Mean 
severity3 
(95% CI) 
10-12 
months 
    
n = 41 Getting more support from 
family  
13 32 (24, 39) 4.4 (4.1, 4.7)  
 Reducing patient’s stress      10 24 (18, 31) 4.5  (4.1, 4.9) 
 Addressing sex life problems       10 24 (18, 31) 4.2  (3.9, 4.5) 
  Accessing prognosis 
information 
9 22 (16, 28) 4.4  (4.0, 4.8) 
 Accessing treatment 
information      
9 22 (16, 28) 4.4  (4.0, 4.8) 
 Managing concerns about 
recurrence 
9 22 (16, 28) 4.6  (4.2, 5.0) 
 Having opportunity to discuss 
concern with doctor 
9 22 (16, 28) 4.4  (4.0, 4.8) 
 Handling topic of cancer in 
social situations   
9 22 (16, 28) 4.4  (4.0, 4.8) 
 Working through feelings 
about death and dying 
9 22 (16, 28) 4.4  (4.0, 4.8) 
7-9 months     
n = 50 Reducing patient’s stress            19 38 (31, 45) 4.3  (4.0, 4.5) 
 Handling topic of cancer in 
social situations   
15 30 (24, 37) 4.1  (3.9, 4.3) 
 Accessing prognosis 
information      
11 22 (16, 28) 4.5  (4.2, 4.9) 
 Accessing treatment 
information              
11 22 (16, 28) 4.5  (4.1, 4.8) 
  Accessing information about 
patient’s physical needs             
11 22 (16, 28) 4.3  (4.0, 4.6) 
 Getting emotional support for 
loved ones   
11 22 (16, 28) 4.4  (4.0, 4.7) 
4-6 months     
n = 52 Reducing patient’s stress         22 42 (36, 49) 4.4  (4.1, 4.6) 
 Accessing prognosis 
information      
20 39 (32, 45) 4.3  (4.0, 4.5) 
 Dealing with lack of 
acknowledgement of impact of 
being carer    
20 39 (32, 45) 4.2 (4.0, 4.4) 
 Accessing information about 
patient’s physical needs             
19 37 (30, 43) 4.3  (4.0, 4.5) 
 27 
 Parking                  18 35 (28, 41) 4.4  (4.1, 4.6) 
0-3 months     
n = 26 Reducing patient’s stress           11 42 (33, 52) 4.4 (4.0, 4.7) 
 Disappointment about 
recovery     
11 42 (33, 52) 4.4 (4.0, 4.7) 
 Fears of cancer spreading         10 39 (29, 48) 4.4 (4.0, 4.8) 
 Making decisions in context of 
uncertainty        
10 39 (29, 48) 4.5 (4.1, 4.9) 
 Parking 9 35 (25, 44) 4.8 (4.4, 5.1) 
 Impact of caring on work and 
activities 
9 35 (25, 44) 4.6 (4.2, 5.0) 
 Balancing own needs with 
patient’s 
9 35 (25, 44) 4.6 (4.2, 5.0) 
 Accessing prognosis 
information           
9 35 (25, 44) 4.2 (3.9, 4.6) 
1 Each of the needs was measured on a scale which stated “In the last month, what was 456 
your level of need for help with”, where response options were 1 = “not applicable”, 2 = 457 
“satisfied”, 3 = “Low need”, 4 = “Moderate need”, 5 = “High need”. 458 
2Prevalence is the proportion of caregivers reporting 3 or greater  459 
3Amongst caregivers with any unmet need 460 
461 
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Table 4. Association of caregiver mental and physical quality of life, and distress 462 
with psychological variables while controlling for months to death, age, social 463 
support, and patient’s quality of life. 464 
 465 
  Baseline predicts later1 Time varying2 
Outcome Explanatory variable Estimate3 (95% CI) p-value Estimate3 (95% CI) p-value 
Mental Wellbeing Optimism 0.6 (0.2, 1.1) 0.01 0.6 (0.4, 0.9) <0.0001 
 Unmet needs -0.1 (-0.3, 0.02) 0.08 -0.1 (-0.2, -0.05) 0.008 
 Physical wellbeing -0.07 (-0.3, 0.1) 0.4 -0.3 (-0.4, -0.2) <0.0001 
 Social support 0.5 (0.2, 0.9) 0.002 0.5 (0.3, 0.7) <0.0001 
 Caregiver Age (per 
10 years) 
0.2 (-1.6, 1.9) 0.8 0.4 (-0.7, 0.15) 0.4 
 Months to death 0.3 (-0.3, 0.9) 0.3 0.3 (-0.03, 0.6) 0.07 
 Patient QoL  -0.2 (-0.3, -0.04) 0.02 -0.003 (-0.08, 0.08) 0.9 
      
Physical Wellbeing Optimism  0.5 (-0.3, 1.2) 0.3   0.2 (-0.2, 0.5) 0.4 
 Unmet needs -0.1 (-0.4, 0.07) 0.2 -0.04 (-0.2, 0.5) 0.4 
 Mental wellbeing -0.2 (-0.6, 0.2) 0.3  -0.4 (-0.12, 0.04) <0.0001 
 Social support 0.2 (-0.3, 0.7) 0.5   0.3 (0.04, 0.5) 0.02 
 Caregiver Age (per 
10 years) 
-1.8 (-4.3, 0.7) 0.2  -1.3 (-2.9, 0.3) 0.1 
 Months to death -0.2 (-0.7, 0.3) 0.4 -0.07 (-0.4, 0.2 ) 0.7 
 Patient QoL  0.03 (-0.2, 0.3) 0.8  0.05 (-0.04, 0.1) 0.3 
      
Distress Optimism -0.5 (-0.8, -0.2) 0.009 -0.5 (-0.7, -0.4) <0.0001 
 Unmet needs 0.1 (0.02, 0.2) 0.02 0.08 (0.04, 0.1) 0.0005 
 Physical wellbeing 0.03 (-0.09, 0.1) 0.7 -0.02 (-0.1, 0.05) 0.5 
 Social support -0.2 (-0.4, -0.04) 0.02 -0.3 (-0.4, -0.2) <0.0001 
 Caregiver Age (per 
10 years) 
0.3 (-0.8, 1.3 ) 0.6 -0.1 (-0.9, 0.6) 0.8 
 Months to death -0.1 (-0.4, 0.2 ) 0.5 -0.3 (-0.5, -0.08) 0.005 
 Patient QoL  0.05 (-0.5, 0.1) 0.3 -0.02 (-0.07, 0.03) 0.5 
1 Each caregiver’s first observation in the year preceding death for psychosocial variables was used to 466 
predict all subsequent observations of QoL. 467 
2 Variables are allowed to vary with time. 468 
3Regression coefficient estimates and 95% confidence intervals from a mixed model are shown. 469 
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 475 
Figure 1. Mean mental and physical wellbeing, unmet needs, social support, optimism 476 
and depression over months to death, with 95% confidence intervals.  Distress is the only 477 
outcome with a significant increase over time (p = 0.01). 478 
 479 
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